International Biotechnology Trust PLC Novo Cure LTD Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Novo Cure LTD stock. As of the latest transaction made, International Biotechnology Trust PLC holds 74,000 shares of NVCR stock, worth $2.15 Million. This represents 0.41% of its overall portfolio holdings.
Number of Shares
74,000
Previous 32,000
131.25%
Holding current value
$2.15 Million
Previous $1.33 Million
10.02%
% of portfolio
0.41%
Previous 0.41%
Shares
5 transactions
Others Institutions Holding NVCR
# of Institutions
262Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$352 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$344 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$230 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA4.31MShares$125 Million0.01% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$87.9 Million12.67% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $3.04B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...